Janus Henderson Group’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103M | Sell |
4,460,332
-137,760
| -3% | -$3.18M | 0.05% | 257 |
|
|
2025
Q1 | $134M | Buy |
4,598,092
+1,035,690
| +29% | +$30.1M | 0.07% | 227 |
|
|
2024
Q4 | $191M | Buy |
3,562,402
+1,038,996
| +41% | +$55.6M | 0.1% | 198 |
|
|
2024
Q3 | $115M | Buy |
2,523,406
+721,563
| +40% | +$32.8M | 0.06% | 257 |
|
|
2024
Q2 | $75.4M | Sell |
1,801,843
-163,703
| -8% | -$6.85M | 0.04% | 302 |
|
|
2024
Q1 | $74M | Buy |
1,965,546
+34,069
| +2% | +$1.28M | 0.04% | 314 |
|
|
2023
Q4 | $20.7M | Sell |
1,931,477
-135,991
| -7% | -$1.46M | 0.01% | 541 |
|
|
2023
Q3 | $20.8M | Sell |
2,067,468
-41,870
| -2% | -$422K | 0.01% | 521 |
|
|
2023
Q2 | $25M | Buy |
2,109,338
+240,262
| +13% | +$2.85M | 0.02% | 519 |
|
|
2023
Q1 | $22.6M | Buy |
1,869,076
+31,285
| +2% | +$378K | 0.01% | 550 |
|
|
2022
Q4 | $24.2M | Sell |
1,837,791
-2,082,297
| -53% | -$27.4M | 0.02% | 525 |
|
|
2022
Q3 | $53.1M | Buy |
3,920,088
+1,792,291
| +84% | +$24.3M | 0.02% | 502 |
|
|
2022
Q2 | $26M | Sell |
2,127,797
-211,349
| -9% | -$2.58M | 0.02% | 516 |
|
|
2022
Q1 | $33.5M | Sell |
2,339,146
-61,747
| -3% | -$885K | 0.02% | 619 |
|
|
2021
Q4 | $46.6M | Sell |
2,400,893
-15,511
| -0.6% | -$301K | 0.02% | 566 |
|
|
2021
Q3 | $51.4M | Sell |
2,416,404
-251,803
| -9% | -$5.35M | 0.02% | 546 |
|
|
2021
Q2 | $64.5M | Buy |
+2,668,207
| New | +$64.5M | 0.03% | 502 |
|